George Hill
Stock Analyst at Deutsche Bank
(2.96)
# 1,400
Out of 5,124 analysts
190
Total ratings
54.39%
Success rate
5.91%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Downgrades: Hold | $332 → $320 | $371.37 | -13.83% | 3 | Dec 19, 2025 | |
| HUM Humana | Maintains: Hold | $250 → $231 | $279.84 | -17.45% | 12 | Nov 7, 2025 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $826.51 | +3.57% | 8 | Sep 24, 2025 | |
| HQY HealthEquity | Maintains: Buy | $98 → $115 | $95.45 | +20.48% | 18 | Jun 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $348.97 | +3.73% | 22 | May 14, 2025 | |
| CVS CVS Health | Maintains: Buy | $66 → $70 | $80.70 | -13.26% | 7 | Feb 14, 2025 | |
| AGL agilon health | Maintains: Hold | $4 → $2 | $0.82 | +145.10% | 16 | Nov 8, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $23 → $27 | $35.46 | -23.86% | 4 | Nov 6, 2024 | |
| CI The Cigna Group | Maintains: Buy | $398 → $394 | $284.76 | +38.36% | 10 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Hold | $119 → $124 | $208.48 | -40.52% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $12 | $8.00 | +50.00% | 18 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $4.21 | -52.49% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $32.53 | -4.70% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $2.54 | +96.85% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $45.74 | +90.21% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $184.73 | +91.09% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $292.79 | +60.87% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.90 | +175.86% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $240.53 | +3.94% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $201.48 | +16.64% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $216.11 | +54.55% | 5 | Feb 18, 2021 |
Elevance Health
Dec 19, 2025
Downgrades: Hold
Price Target: $332 → $320
Current: $371.37
Upside: -13.83%
Humana
Nov 7, 2025
Maintains: Hold
Price Target: $250 → $231
Current: $279.84
Upside: -17.45%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $826.51
Upside: +3.57%
HealthEquity
Jun 5, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $95.45
Upside: +20.48%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $348.97
Upside: +3.73%
CVS Health
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $80.70
Upside: -13.26%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.82
Upside: +145.10%
Hims & Hers Health
Nov 6, 2024
Maintains: Hold
Price Target: $23 → $27
Current: $35.46
Upside: -23.86%
The Cigna Group
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $284.76
Upside: +38.36%
Cardinal Health
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $208.48
Upside: -40.52%
Nov 1, 2024
Maintains: Hold
Price Target: $10 → $12
Current: $8.00
Upside: +50.00%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $4.21
Upside: -52.49%
Aug 14, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $32.53
Upside: -4.70%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $2.54
Upside: +96.85%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $45.74
Upside: +90.21%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $184.73
Upside: +91.09%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $292.79
Upside: +60.87%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.90
Upside: +175.86%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $240.53
Upside: +3.94%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $201.48
Upside: +16.64%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $216.11
Upside: +54.55%